[Primary surgery in the treatment of invasive cancer of the cervix uteri].
The statistical data reported in this study show that the results obtained with surgery in invasive carcinoma of the cervix uteri are equivalent to those obtained with radiotherapy alone or associated with surgery. The overall proportion of operable patients in this series was 94% (stage I: 98%, stage II: 89%, stage III: 72% and stage IV: 23%). The overall survival rates at 5 years were 90.7% for stage I patients (stage I A 98.0%, stage I B 84.9%), 54.6% for stage II patients (stage II A 68.9%, stage II B proximal 67.1%, stage II B distal 25%). 20.2% for stage III patients and 7.6% for stage IV patients. The drawbacks (mortality, morbidity) of surgery and its advantages (lower psychological and financial cost) are examined. The possibility to adjust the surgical operation to the local and regional extension of the cancerous lesions and the indications for supplementary radiotherapy are discussed.
D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D009361:Neoplasm Invasiveness; D011183:Postoperative Complications; D013997:Time Factors; D002583:Uterine Cervical Neoplasms / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery*
La chirurgie première dans le traitement du cancer invasif du col utérin.